Market News AIOpen the app

SRRK stock news · Scholar Rock Holding Corp

Stories about Scholar Rock Holding Corp (SRRK) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for SRRK

Follow Scholar Rock Holding Corp (SRRK) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for SRRK
Free on the App Store and Google Play, or on the web.
  1. Nov 10, 2026, 7:19 AM ET · Market

    Scholar Rock Holding Corp will sell a Rare Pediatric Disease Priority Review Voucher to BioNTech for $205 million.

    Good for SRRK

    Scholar Rock agreed to sell an FDA voucher for $205 million in cash, subject to closing conditions. The sale would bring cash to the company, making the news favorable.

  2. Oct 5, 2026, 8:57 AM ET · Results

    Scholar Rock Holding shares its financial results for the second quarter of 2026, including the full earnings call details.

    Good for SRRK

    Scholar Rock says FDA review is progressing and it is ready to launch apitegromab in the U.S. by September 30, supporting a positive read despite pending approval.

  3. Sep 14, 2026, 9:35 AM ET · Market

    Scholar Rock celebrates a big milestone with its first treatment for spinal muscular atrophy.

    Good for SRRK

    FDA approval and an immediate U.S. launch make Scholar Rock's commercial outlook more positive as ISEMBYLD ships to customers.